Journal
NEUROSCIENCE LETTERS
Volume 583, Issue -, Pages 16-20Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2014.09.013
Keywords
Erythropoietin; Intranasal delivery; EpoR phosphorylation; Ischemia; Neuroprotection
Categories
Funding
- Consejo Nacional de Ciencia y Tecnologia (CONACYT) [381861/253971]
- Universidad de Guadalajara, Mexico [P3E-221023]
Ask authors/readers for more resources
Erythropoietin in the nervous system is a potential neuroprotective factor for cerebral ischemic damage due to specific-binding to the erythropoietin receptor, which is associated with survival mechanisms. However, the role of its receptor is unclear. Thus, this work assessed whether a low dose (500 UI/Kg) of intranasal recombinant human erythropoietin administered 3 h after ischemia induced changes in the activation of its receptor at the Tyr456-phosphorylated site in ischemic hippocampi in rats. The results showed that recombinant human erythropoietin after injury maintained cell survival and was associated with an increase in receptor phosphorylation at the Tyr456 site as an initial signaling step, which correlated with a neuroprotective effect. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available